Trial Profile
A Single-Dose Pharmacokinetics And Relative Bioavailability Study Of Tolterodine From Two Microspheres In Powder Blend Extended Release Formulations Compared To The Commercial Extended Release Capsules
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2021
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- Sponsors Pfizer
- 03 Feb 2012 New trial record